Rasagilin Accord 1 mg Tabletten
The marketing authorisation holder informed its customers on September 02, 2022 that the nitrosamine levels of the listed batch is above the permitted acceptable daily dose. As a precautionary measure, the affected batch is recalled.
|Name of the medicinal product||Rasagilin Accord 1 mg Tabletten|
|Marketing authorisation number(s)||136675|
|Marketing authorisation holder||Accord Healthcare B.V.|
|Classification of the recall||2|
|Depth of recall||Pharmacies|
|BASG reference number||INS-640.001-3816|